A turbulent 2024 for Neurocrine is ending on a high note, after the biotech won FDA approval to treat congenital adrenal hyperplasia, a condition marked …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Claire Panosian Dunavan is a professor of medicine and infectious diseases at the David Geffen School of Medicine at UCLA and a past-president of the
CHICAGO — The public health infrastructure in this country needs more support and funding from the federal government, American Medical Association (AMA) House of Delegates
Dietary and lifestyle interventions that might help reduce cardiometabolic risk in women with polycystic ovary syndrome.